Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Balaxi Pharmaceuticals Limited ( (IN:BALAXI) ) is now available.
Balaxi Pharmaceuticals Limited has announced the closure of its trading window for designated persons and their immediate relatives from April 1, 2026, in line with SEBI’s Prohibition of Insider Trading Regulations and its internal code of conduct. The restriction will remain in force until 48 hours after the company announces its audited financial results for the fourth quarter and full year ended March 31, 2026, with the board meeting date for approving these results to be communicated later, signaling the upcoming earnings disclosure cycle to investors and other stakeholders.
More about Balaxi Pharmaceuticals Limited
Balaxi Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the development, manufacture and sale of pharmaceutical products. The company’s shares are listed on the National Stock Exchange of India, and it is subject to Indian securities market regulations, including insider trading and disclosure norms.
Average Trading Volume: 169,035
Technical Sentiment Signal: Sell
Current Market Cap: 979.4M INR
For a thorough assessment of BALAXI stock, go to TipRanks’ Stock Analysis page.